Great Lakes Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-823
| Closed | -$399K | – | 874 |
|
|
2025
Q1 | $399K | Buy |
823
+31
| +4% | +$15K | ﹤0.01% | 644 |
|
|
2024
Q4 | $319K | Sell |
792
-27
| -3% | -$10.9K | ﹤0.01% | 713 |
|
|
2024
Q3 | $381K | Sell |
819
-890
| -52% | -$414K | ﹤0.01% | 694 |
|
|
2024
Q2 | $801K | Sell |
1,709
-2,505
| -59% | -$1.17M | 0.01% | 598 |
|
|
2024
Q1 | $1.76M | Buy |
4,214
+2,406
| +133% | +$1.01M | 0.01% | 487 |
|
|
2023
Q4 | $736K | Buy |
+1,808
| New | +$736K | 0.01% | 559 |
|
|
2021
Q3 | – | Sell |
-1,201
| Closed | -$242K | – | 740 |
|
|
2021
Q2 | $242K | Buy |
+1,201
| New | +$242K | ﹤0.01% | 625 |
|
|
2020
Q3 | – | Sell |
-815
| Closed | -$237K | – | 625 |
|
|
2020
Q2 | $237K | Buy |
+815
| New | +$237K | 0.01% | 514 |
|
|
2019
Q3 | – | Sell |
-1,289
| Closed | -$236K | – | 580 |
|
|
2019
Q2 | $236K | Sell |
1,289
-1,001
| -44% | -$183K | 0.01% | 507 |
|
|
2019
Q1 | $421K | Buy |
2,290
+733
| +47% | +$135K | 0.01% | 472 |
|
|
2018
Q4 | $258K | Sell |
1,557
-120
| -7% | -$19.9K | 0.01% | 502 |
|
|
2018
Q3 | $323K | Buy |
+1,677
| New | +$323K | 0.01% | 514 |
|